【藥品性質提示】 ★LASA藥品：REL01 Relvar Ellipta 吸入劑 藍 92/22 (形似) 點擊看LASA藥品外觀比較圖 【藥品訊息】 【184/22】Relvar Ellipta 吸入劑 衛教單張

氣喘 Asthma

Fluticasone: Corticosteroid, Inhalant
A corticosteroid with anti-inflammatory activity, immunosuppressive properties, and antiproliferative actions.
Vilanterol: Beta2-Adrenergic Agonist, Long-Acting
A long-acting beta2-agonist, relaxes bronchial smooth muscle by selective action on beta2-receptors with little effect on heart rate.

1. Hypersensitivity to fluticasone, vilanterol, or any component of the formulation
2. Severe hypersensitivity to milk proteins
3. Primary treatment of status asthmaticus or other acute episodes of COPD or asthma where intensive measures are required

Adverse events have not been observed in animal reproduction studies

It is not known if sufficient quantities of fluticasone or vilanterol are absorbed following inhalation to produce detectable amounts in breast milk.

Asthma: One inhalation once daily. (MAX 1 inhalation once daily)

No dosage adjustment necessary.

1. Mild impairment: There are no dosage adjustments provided in the manufacturer's labeling.
2. Moderate to severe impairment: There are no dosage adjustments provided in the manufacturer's labeling; however, systemic fluticasone exposure may be increased up to threefold in patients with hepatic impairment; use with caution and monitor closely.